Climb Bio, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2025 Annual Meeting of Stockholders held by Climb Bio, Inc. on June 4, 2025. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol CLYM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Director Elections: Stockholders elected Judith Dunn, Ph.D., and Stephen Thomas, Ph.D., to the Board of Directors for three-year terms expiring in 2028.
- Judith Dunn, Ph.D.: 36,827,909 votes For; 6,615,228 votes Withheld; 10,126,633 Broker Non-Votes.
- Stephen Thomas, Ph.D.: 41,359,959 votes For; 2,083,178 votes Withheld; 10,126,633 Broker Non-Votes.
- Auditor Ratification: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Results: 53,442,396 votes For; 8,780 votes Against; 118,594 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation of the new board composition following the election of Dr. Dunn and Dr. Thomas.
- Verification of the significant number of broker non-votes (over 10 million) regarding the director elections.
- Confirmation that PricewaterhouseCoopers LLP will serve as the auditor for the 2025 fiscal year.